Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix
- Autores
- Ramírez, N.; Guerra, Fernando Andres; Camporeale, Gabriela; Quintana, S.; Diaz, L. B.; Cuneo, N.; Villacorta Hidalgo, J.; Tatti, S. A.; Alonso, Leonardo Gabriel; Borkosky, Silvia Susana; de Prat Gay, Gonzalo; Palaoro, L.
- Año de publicación
- 2015
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Continuous production of the E7 protein from different types of high risk human papilloma virus (HPV) is required for progression of malignancy. We developed antibodies against HPV type 16 E7 and E2 proteins to evaluate their utility as markers for diagnosis during early stages of cervical cancer. Forty biopsies from uterine cervices were diagnosed as low grade intraepithelial lesion (LSIL), high grade intraepithelial lesion (HSIL), squamous carcinoma (SC), in situ adenocarcinoma (ISA) and invasive adenocarcinoma (AC), all of which were infected with HPV 16. Immunohistochemistry was used to investigate the expressions of E7 and E2 (both from HPV 16) and p16. P16 was expressed in eight of 12 LSILs, in all HSILs, in 16 of 18 SC and in all ACs. E2 was expressed in six of 12 LSILs. E7 was positive in eight of 12 LSILs and in all HSIL and carcinomas. The expressions of E2 and E7 of HPV16 related to p16 expression confirmed the value of the viral oncogenic proteins as complementary to histology and support the carcinogenic model of the uterine cervix, because HPVDNA integration into cellular DNA implies the destruction of the gene encoding E2, which suppresses the expression of the E6 and E7 oncoproteins. E2 from HPV16 could be marker for LSILs, while E7 could be a marker for progression of LSILs to HSILs in patients infected by HPV16, because viral typing has little positive predictive value.
Fil: Ramírez, N.. Furtwangen University; Alemania
Fil: Guerra, Fernando Andres. Universidad de Buenos Aires. Hospital de Clínicas; Argentina
Fil: Camporeale, Gabriela. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina
Fil: Quintana, S.. Instituto Fares Taie. Laboratorio de Biología Molecular; Argentina
Fil: Diaz, L. B.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina
Fil: Cuneo, N.. Hospital de Oncología María Curie; Argentina
Fil: Villacorta Hidalgo, J.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina
Fil: Tatti, S. A.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina
Fil: Alonso, Leonardo Gabriel. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina
Fil: Borkosky, Silvia Susana. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina
Fil: de Prat Gay, Gonzalo. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina
Fil: Palaoro, L.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina - Materia
-
Adenocarcinoma
Biomarkers
Papillomavirus - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/14464
Ver los metadatos del registro completo
id |
CONICETDig_341962d2a792ef358fc175ac8f6e914b |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/14464 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervixRamírez, N.Guerra, Fernando AndresCamporeale, GabrielaQuintana, S.Diaz, L. B.Cuneo, N.Villacorta Hidalgo, J.Tatti, S. A.Alonso, Leonardo GabrielBorkosky, Silvia Susanade Prat Gay, GonzaloPalaoro, L.AdenocarcinomaBiomarkersPapillomavirushttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Continuous production of the E7 protein from different types of high risk human papilloma virus (HPV) is required for progression of malignancy. We developed antibodies against HPV type 16 E7 and E2 proteins to evaluate their utility as markers for diagnosis during early stages of cervical cancer. Forty biopsies from uterine cervices were diagnosed as low grade intraepithelial lesion (LSIL), high grade intraepithelial lesion (HSIL), squamous carcinoma (SC), in situ adenocarcinoma (ISA) and invasive adenocarcinoma (AC), all of which were infected with HPV 16. Immunohistochemistry was used to investigate the expressions of E7 and E2 (both from HPV 16) and p16. P16 was expressed in eight of 12 LSILs, in all HSILs, in 16 of 18 SC and in all ACs. E2 was expressed in six of 12 LSILs. E7 was positive in eight of 12 LSILs and in all HSIL and carcinomas. The expressions of E2 and E7 of HPV16 related to p16 expression confirmed the value of the viral oncogenic proteins as complementary to histology and support the carcinogenic model of the uterine cervix, because HPVDNA integration into cellular DNA implies the destruction of the gene encoding E2, which suppresses the expression of the E6 and E7 oncoproteins. E2 from HPV16 could be marker for LSILs, while E7 could be a marker for progression of LSILs to HSILs in patients infected by HPV16, because viral typing has little positive predictive value.Fil: Ramírez, N.. Furtwangen University; AlemaniaFil: Guerra, Fernando Andres. Universidad de Buenos Aires. Hospital de Clínicas; ArgentinaFil: Camporeale, Gabriela. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; ArgentinaFil: Quintana, S.. Instituto Fares Taie. Laboratorio de Biología Molecular; ArgentinaFil: Diaz, L. B.. Universidad de Buenos Aires. Hospital de Clínicas; ArgentinaFil: Cuneo, N.. Hospital de Oncología María Curie; ArgentinaFil: Villacorta Hidalgo, J.. Universidad de Buenos Aires. Hospital de Clínicas; ArgentinaFil: Tatti, S. A.. Universidad de Buenos Aires. Hospital de Clínicas; ArgentinaFil: Alonso, Leonardo Gabriel. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; ArgentinaFil: Borkosky, Silvia Susana. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; ArgentinaFil: de Prat Gay, Gonzalo. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; ArgentinaFil: Palaoro, L.. Universidad de Buenos Aires. Hospital de Clínicas; ArgentinaInforma Healthcare2015-06-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/14464Ramírez, N.; Guerra, Fernando Andres; Camporeale, Gabriela; Quintana, S.; Diaz, L. B.; et al.; Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix; Informa Healthcare; Biotechnic And Histochemistry; 90; 8; 08-6-2015; 573-5801473-7760enginfo:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.3109/10520295.2015.1047794info:eu-repo/semantics/altIdentifier/doi/10.3109/10520295.2015.1047794info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:00:55Zoai:ri.conicet.gov.ar:11336/14464instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:00:55.826CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix |
title |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix |
spellingShingle |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix Ramírez, N. Adenocarcinoma Biomarkers Papillomavirus |
title_short |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix |
title_full |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix |
title_fullStr |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix |
title_full_unstemmed |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix |
title_sort |
Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix |
dc.creator.none.fl_str_mv |
Ramírez, N. Guerra, Fernando Andres Camporeale, Gabriela Quintana, S. Diaz, L. B. Cuneo, N. Villacorta Hidalgo, J. Tatti, S. A. Alonso, Leonardo Gabriel Borkosky, Silvia Susana de Prat Gay, Gonzalo Palaoro, L. |
author |
Ramírez, N. |
author_facet |
Ramírez, N. Guerra, Fernando Andres Camporeale, Gabriela Quintana, S. Diaz, L. B. Cuneo, N. Villacorta Hidalgo, J. Tatti, S. A. Alonso, Leonardo Gabriel Borkosky, Silvia Susana de Prat Gay, Gonzalo Palaoro, L. |
author_role |
author |
author2 |
Guerra, Fernando Andres Camporeale, Gabriela Quintana, S. Diaz, L. B. Cuneo, N. Villacorta Hidalgo, J. Tatti, S. A. Alonso, Leonardo Gabriel Borkosky, Silvia Susana de Prat Gay, Gonzalo Palaoro, L. |
author2_role |
author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Adenocarcinoma Biomarkers Papillomavirus |
topic |
Adenocarcinoma Biomarkers Papillomavirus |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Continuous production of the E7 protein from different types of high risk human papilloma virus (HPV) is required for progression of malignancy. We developed antibodies against HPV type 16 E7 and E2 proteins to evaluate their utility as markers for diagnosis during early stages of cervical cancer. Forty biopsies from uterine cervices were diagnosed as low grade intraepithelial lesion (LSIL), high grade intraepithelial lesion (HSIL), squamous carcinoma (SC), in situ adenocarcinoma (ISA) and invasive adenocarcinoma (AC), all of which were infected with HPV 16. Immunohistochemistry was used to investigate the expressions of E7 and E2 (both from HPV 16) and p16. P16 was expressed in eight of 12 LSILs, in all HSILs, in 16 of 18 SC and in all ACs. E2 was expressed in six of 12 LSILs. E7 was positive in eight of 12 LSILs and in all HSIL and carcinomas. The expressions of E2 and E7 of HPV16 related to p16 expression confirmed the value of the viral oncogenic proteins as complementary to histology and support the carcinogenic model of the uterine cervix, because HPVDNA integration into cellular DNA implies the destruction of the gene encoding E2, which suppresses the expression of the E6 and E7 oncoproteins. E2 from HPV16 could be marker for LSILs, while E7 could be a marker for progression of LSILs to HSILs in patients infected by HPV16, because viral typing has little positive predictive value. Fil: Ramírez, N.. Furtwangen University; Alemania Fil: Guerra, Fernando Andres. Universidad de Buenos Aires. Hospital de Clínicas; Argentina Fil: Camporeale, Gabriela. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina Fil: Quintana, S.. Instituto Fares Taie. Laboratorio de Biología Molecular; Argentina Fil: Diaz, L. B.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina Fil: Cuneo, N.. Hospital de Oncología María Curie; Argentina Fil: Villacorta Hidalgo, J.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina Fil: Tatti, S. A.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina Fil: Alonso, Leonardo Gabriel. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina Fil: Borkosky, Silvia Susana. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina Fil: de Prat Gay, Gonzalo. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina Fil: Palaoro, L.. Universidad de Buenos Aires. Hospital de Clínicas; Argentina |
description |
Continuous production of the E7 protein from different types of high risk human papilloma virus (HPV) is required for progression of malignancy. We developed antibodies against HPV type 16 E7 and E2 proteins to evaluate their utility as markers for diagnosis during early stages of cervical cancer. Forty biopsies from uterine cervices were diagnosed as low grade intraepithelial lesion (LSIL), high grade intraepithelial lesion (HSIL), squamous carcinoma (SC), in situ adenocarcinoma (ISA) and invasive adenocarcinoma (AC), all of which were infected with HPV 16. Immunohistochemistry was used to investigate the expressions of E7 and E2 (both from HPV 16) and p16. P16 was expressed in eight of 12 LSILs, in all HSILs, in 16 of 18 SC and in all ACs. E2 was expressed in six of 12 LSILs. E7 was positive in eight of 12 LSILs and in all HSIL and carcinomas. The expressions of E2 and E7 of HPV16 related to p16 expression confirmed the value of the viral oncogenic proteins as complementary to histology and support the carcinogenic model of the uterine cervix, because HPVDNA integration into cellular DNA implies the destruction of the gene encoding E2, which suppresses the expression of the E6 and E7 oncoproteins. E2 from HPV16 could be marker for LSILs, while E7 could be a marker for progression of LSILs to HSILs in patients infected by HPV16, because viral typing has little positive predictive value. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-06-08 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/14464 Ramírez, N.; Guerra, Fernando Andres; Camporeale, Gabriela; Quintana, S.; Diaz, L. B.; et al.; Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix; Informa Healthcare; Biotechnic And Histochemistry; 90; 8; 08-6-2015; 573-580 1473-7760 |
url |
http://hdl.handle.net/11336/14464 |
identifier_str_mv |
Ramírez, N.; Guerra, Fernando Andres; Camporeale, Gabriela; Quintana, S.; Diaz, L. B.; et al.; Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix; Informa Healthcare; Biotechnic And Histochemistry; 90; 8; 08-6-2015; 573-580 1473-7760 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.3109/10520295.2015.1047794 info:eu-repo/semantics/altIdentifier/doi/10.3109/10520295.2015.1047794 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Informa Healthcare |
publisher.none.fl_str_mv |
Informa Healthcare |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613796402823168 |
score |
13.070432 |